(Q42281368)

19 October 2017

title

Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA. (English)

1 reference

19 October 2017

Sakurai M

1

1 reference

19 October 2017

Higashida S

2

1 reference

19 October 2017

Sugano M

3

1 reference

19 October 2017

Komai T

4

1 reference

19 October 2017

Yagi R

5

1 reference

19 October 2017

Ozawa Y

6

1 reference

19 October 2017

Handa H

7

1 reference

19 October 2017

Nishigaki T

8

1 reference

19 October 2017

Yabe Y

9

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 August 1994

1 reference

Bioorganic & Medicinal Chemistry

19 October 2017

published in

1 reference

19 October 2017

volume

2

1 reference

19 October 2017

issue

8

1 reference

19 October 2017

page(s)

807-825

1 reference

Challenges in the therapy of HIV infection

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Proteolytic processing of polyproteins in the replication of RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

HIV proteinase as a target for drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

The chronically infected cell as a target for the treatment of HIV infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

HIV protease: a novel chemotherapeutic target for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Sequence specificity of retroviral proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

1 reference

7 January 2021

Studies of HIV-1 protease inhibitors. I. Incorporation of a reduced peptide, simple aminoalcohol, and statine analog at the scissile site of substrate sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Studies of human immunodeficiency virus type 1 (HIV-1) protease inhibitors. III. Structure-activity relationship of HIV-1 protease inhibitors containing cyclohexylalanylalanine hydroxyethylene dipeptide isostere

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Substrate analog inhibitors of HIV-1 protease containing phenylnorstatine as a transition state element

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Intriguing structure-activity relations underlie the potent inhibition of HIV protease by norstatine-based peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Kynostatin (KNI)-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Effect of hydroxyl group configuration in hydroxyethylamine dipeptide isosteres on HIV protease inhibition. Evidence for multiple binding modes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Rational design of peptide-based HIV proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

L-687,908, a potent hydroxyethylene-containing HIV protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Pepstatin, a new pepsin inhibitor produced by Actinomycetes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Biological activity of pepstatins, pepstanone A and partial peptides on pepsin, cathepsin D and renin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

Synthesis and structure-activity relationships of bestatin analogues, inhibitors of aminopeptidase B

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982181-1

7 January 2021

10.1016/S0968-0896(00)82181-1

Identifiers

DOI

1 reference

19 October 2017

1 reference